AN2 Therapeutics is a clinical-stage biopharmaceutical company focused on novel medicines targeting infectious diseases.
Appello Pharmaceuticals is a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease.
Boragen is a small molecule development company focused on leveraging the unique chemical properties of Boron chemistry, both in crop protection and animal health.
Castle Biosciences is focused on developing and commercializing molecular diagnostics to aid health care professionals in assessing types and sub-types of tumors. Products focus on differentiating tumor types at the molecular level using various means of analyzing and comparing components of DNA.
Cerebrotech Medical Systems
Cerebrotech Medical Systems has developed a non-invasive, continuous monitor for early detection of cerebral fluid change (primarily edema or bleeding) that can occur in a number of neurologic conditions, including stroke, traumatic brain injury, post brain surgery, etc.
Mindera Health has developed a proprietary micro biopsy tool used to extract a patient’s transcriptome. After processing via next-generation sequencing and analysis, dermatologists will be able to make personalized diagnoses and track disease progression.
PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company committed to developing improved biotherapeutics for the treatment of orphan diseases, with an initial focus on cardiopulmonary indications.